Intraluminal Therapy for Helicobacter Pylori Infection

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 28, 2017

Primary Completion Date

December 31, 2017

Study Completion Date

April 30, 2018

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Lansoprazole

Group A: lansoprazole 30 mg b.i.d. for 7 days Group B: lansoprazole 30 mg b.i.d. for 14 days

DRUG

Amoxicillin

Group A: amoxicillin 1 g b.i.d. for 7 days Group B: amoxicillin 1 g b.i.d. for 14 days

DRUG

Clarithromycin

Group A: clarithromycin 500 mg b.i.d. for 7 days Group B: clarithromycin 500 mg b.i.d. for 14 days

Trial Locations (1)

10449

Division of Gastroenterology and Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan, Taipei

All Listed Sponsors
lead

Mackay Memorial Hospital

OTHER

NCT03124420 - Intraluminal Therapy for Helicobacter Pylori Infection | Biotech Hunter | Biotech Hunter